The Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, full German name "Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH", also referred to as "Bergmannsheil", formerly known as "Bergbau-Berufsgenossenschaftliche Krankenanstalten Bergmannsheil", is a tertiary teaching hospital in Bochum.

There are 707 beds in Klinikum der Ruhr Universität Bochum.

During the past decade, Klinikum der Ruhr Universität Bochum conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum der Ruhr Universität Bochum" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Ruhr University of Bochum" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Dr. Markus Alfred Möhlenbruch" with 1 trials sponsored and "Hannover Medical School" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum der Ruhr Universität Bochum" #1 collaborator was "Alfried Krupp Krankenhaus" with 1 trials as a collaborator, "Asklepios Kliniken Hamburg GmbH" with 1 trials as a collaborator, "CAPNETZ Stiftung" with 1 trials as a collaborator, "Else Kröner Fresenius Foundation" with 1 trials as a collaborator and "KLINIKUM VEST Recklinghausen" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum der Ruhr Universität Bochum" are "HIV Infections" (2 trials), "Heart Arrest" (2 trials), "Adverse Effect of Handovers of Anesthesia Care" (1 trials), "Anesthesia" (1 trials) and "Chronic Obstructive Pulmonary Disease (COPD)" (1 trials). Many other conditions were trialed in "Klinikum der Ruhr Universität Bochum" in a lesser frequency.

Most popular intervention types in "Klinikum der Ruhr Universität Bochum" are "Drug" (8 trials), "Device" (3 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Avance Solo Adapt NPWT System" (1 trials), "Avance Solo NPWT System" (1 trials), "Best medical care" (1 trials) and "Carfilzomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum der Ruhr Universität Bochum" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum der Ruhr Universität Bochum". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Klinikum der Ruhr Universität Bochum, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum der Ruhr Universität Bochum, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".